Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal? - Wikidata - awgldk - TriplyDB

Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal?

Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal?

http://www.wikidata.org/entity/Q47835640

about

Cytokine Measurements for Diagnosing and Characterizing Leukemoid Reactions and Immunohistochemical Validation of a Granulocyte Colony-Stimulating Factor and CXCL8-Producing Renal Cell Carcinoma

P2860

Q58770354-0D6EB43E-4627-4F3D-A55F-3DB46832179E

P2860

Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal?

http://www.wikidata.org/entity/Q47835640

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal?

@en

Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal?

@nl

type

label

Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal?

@en

Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal?

@nl

prefLabel

Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal?

@en

Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal?

@nl

P1433

Q47835640-F15C3C8F-0577-4B1F-809B-7855DE797A31

P1476

Q47835640-4A6C594F-8BEB-440C-B761-C25B34FFE3BC

P2093

Q47835640-2A04BAAC-1BF4-470C-88DF-C20D06F47C22

Q47835640-3FD3D207-B076-4D9A-B81D-5888CC91DFD2

Q47835640-6F177357-FE47-44A9-8615-B987E3A28776

Q47835640-D3F3E8E1-DA96-4217-AF66-8E80B47D5F6D

P2860

Q47835640-067D822C-4A89-4A63-AD00-21B22A3C696E

Q47835640-06ECC812-F1AE-45FC-A083-A505B8DEA714

Q47835640-077E8C35-7B2C-4A63-A3AB-3BA0BBBC4B36

Q47835640-08AC6DED-7DBF-4C54-995C-19868D2DD14D

Q47835640-11AD6011-800C-4F62-9E19-8272D2962F15

Q47835640-14DF47C8-E794-4A16-8C21-840F7A85A479

Q47835640-1641C997-52B2-4B4B-ADDC-C78E6E22E384

Q47835640-18E49705-23AB-42C7-BB9B-CA167976CBC3

Q47835640-275174B1-4FAD-48BE-9D1F-187B989451E9

Q47835640-2B8D7458-F6DF-43E9-9AF7-FA901144CD9B

P304

Q47835640-510A2C37-08AA-46C0-A929-BE822DF1434F

P31

Q47835640-9150FAAB-3549-42E1-AE70-2A3B8E3E9C85

P356

Q47835640-DD0ADB6E-D04B-4F17-B5D9-67B2849DD3B9

P433

Q47835640-D0797277-1CC8-4D9B-B6F4-3BD123BE107A

P478

Q47835640-BA741307-F71B-4C83-98E2-D5F04F1D607D

P50

Q47835640-07ECA2FE-792F-4561-9374-73B8AC279978

Q47835640-301D974D-597A-4324-9725-5502E6BB97D5

P577

Q47835640-07BEE35E-C22D-4FE8-B5F2-AFBE6B72DED9

P698

Q47835640-818651E0-7A02-4662-86DE-1C9471C92966

P932

Q47835640-C3C18DD8-6638-4873-B252-4BF51A17BCA0

P356

THEONCOLOGIST.2017-0159

P1433

P1476

Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal?

@en

P2093

Dhanusha Sabanathan

http://www.w3.org/2001/XMLSchema#string

Louise Francisco

http://www.w3.org/2001/XMLSchema#string

Manuel Marquez

http://www.w3.org/2001/XMLSchema#string

Natalie Byrne

http://www.w3.org/2001/XMLSchema#string

P2860

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

The interplay of immunotherapy and chemotherapy: harnessing potential synergies

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

Hepatotoxicity with combination of vemurafenib and ipilimumab

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

Immunologic correlates of the abscopal effect in a patient with melanoma

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

Pembrolizumab for the treatment of non-small-cell lung cancer

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

P304

1470-1477

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2017-0159

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29146617

http://www.w3.org/2001/XMLSchema#string

P932

5728040

http://www.w3.org/2001/XMLSchema#string